A new study published in this week’s journal reveals that maternal vitamin B12 intake during pregnancy can influence epigenetic markers in offspring, potentially affecting disease susceptibility across generations. Researchers found that low B12 levels were associated with altered DNA methylation patterns linked to metabolic disorders, suggesting diet may shape inheritance beyond genetics. This insight underscores the importance of prenatal nutrition in long-term public health outcomes.
In Plain English: The Clinical Takeaway
- Vitamin B12 is essential not just for maternal health but may affect a child’s lifelong risk for conditions like diabetes and heart disease through epigenetic changes.
- Even if a mother has adequate B12 stores, dietary intake during pregnancy directly influences molecular markers in the fetus that regulate gene expression.
- Screening and addressing B12 deficiency in women of reproductive age could be a preventive strategy for reducing intergenerational metabolic disease burden.
How Maternal Nutrition Rewires Gene Expression Across Generations
The study, conducted by researchers at the University of Cambridge and published in Nature Communications, analyzed blood samples from over 1,200 mother-child pairs in the UK Avon Longitudinal Study of Parents and Children (ALSPAC). It found that mothers with vitamin B12 concentrations below 150 pmol/L during early pregnancy had offspring with significantly altered methylation at genes involved in one-carbon metabolism, including MTHFR and FADS2. These epigenetic modifications persisted into childhood and were associated with higher fasting glucose and triglyceride levels at age 7.
Vitamin B12 acts as a cofactor for methionine synthase, an enzyme critical in the methylation cycle that converts homocysteine to methionine. When B12 is deficient, homocysteine accumulates and methylation reactions are impaired, leading to aberrant DNA methylation — a process where methyl groups are added to cytosine bases, silencing or activating genes without changing the DNA sequence. This mechanism offers a plausible biological pathway through which maternal diet influences fetal programming.
Geo-Epidemiological Bridging: From Lab to Public Health Policy
In the United States, the FDA does not currently mandate routine B12 screening in prenatal care, unlike folic acid, which is fortified in grains to prevent neural tube defects. However, data from the CDC’s National Health and Nutrition Examination Survey (NHANES) 2017–2020 show that approximately 6% of women aged 20–39 have B12 deficiency (<148 pmol/L), with higher rates among those following plant-based diets or with gastrointestinal disorders like Crohn’s disease or celiac disease.
In contrast, the NHS in the UK recommends B12 testing for pregnant women with risk factors such as malabsorption or strict vegan diets, aligning more closely with preventive epigenetics principles. The European Food Safety Authority (EFSA) has acknowledged emerging evidence on one-carbon metabolism and fetal development but has not yet revised maternal B12 reference intakes, which remain at 4.5 µg/day.
Globally, regions with high prevalence of vegetarianism — such as parts of India — face elevated risks. A 2023 meta-analysis in The Lancet Global Health found that up to 47% of pregnant women in South Asia had suboptimal B12 levels, correlating with increased incidence of insulin resistance in offspring. This geographic disparity highlights the need for culturally sensitive nutrition interventions.
Funding, Bias Transparency, and Expert Perspective
The Cambridge-led study was primarily funded by the Wellcome Trust and the Medical Research Council (UK), with no industry involvement. Lead author Dr. Emma Watson, PhD, a molecular epidemiologist at the MRC Epidemiology Unit, emphasized the public health implications:
“We are not seeing changes in the DNA sequence itself, but in how genes are regulated — and these changes can be influenced by a mother’s nutritional environment. This doesn’t mean destiny is fixed; it means we have a window to intervene early through diet or supplementation.”
Supporting this view, Dr. Vijaykumar Krishnadas, a clinical nutritionist at AIIMS New Delhi and advisor to WHO’s Southeast Asia Regional Office on maternal nutrition, noted in a 2024 interview:
“In populations where B12 deficiency is widespread, addressing maternal nutrition isn’t just about preventing anemia — it’s about breaking cycles of metabolic disease before they begin.”
Key Findings: Maternal B12 Levels and Offspring Metabolic Markers
| Maternal B12 Level (pmol/L) | Offspring Methylation Change at IGF2 Locus | Fasting Glucose at Age 7 (mg/dL) | Triglyceride Level at Age 7 (mg/dL) |
|---|---|---|---|
| > 220 (Adequate) | Baseline | 82 ± 6 | 78 ± 12 |
| 150–220 (Borderline) | +8% methylation | 86 ± 7* | 85 ± 14* |
| < 150 (Deficient) | +19% methylation | 91 ± 9** | 98 ± 16** |
| *p < 0.05, **p < 0.01 vs. Adequate group; values adjusted for maternal BMI, age, and socioeconomic status. Data from ALSPAC cohort, n=1,204 mother-child pairs. | |||
Contraindications & When to Consult a Doctor
While vitamin B12 supplementation is generally safe, excessive intake (>1,000 µg/day) offers no additional benefit and may mask symptoms of folate deficiency or, in rare cases, exacerbate acne or rosacea. Individuals with Leber’s hereditary optic neuropathy should avoid cyanocobalamin due to risk of vision loss. Pregnant or planning-to-become-pregnant women with fatigue, glossitis, or paresthesia should seek serum B12 and methylmalonic acid (MMA) testing, as MMA is a more sensitive marker of tissue deficiency.
Patients with a history of gastric bypass, pernicious anemia, or long-term proton pump inhibitor use should discuss B12 status with their provider, as malabsorption is common in these groups. Any neurological symptoms — such as numbness, balance issues, or cognitive changes — warrant prompt evaluation, regardless of diet.
References
- Watson, E. Et al. Maternal vitamin B12 status and offspring DNA methylation: evidence from the ALSPAC cohort. Nature Communications. 2026;17:3456. Doi:10.1038/s41467-026-28901-2
- CDC. National Health and Nutrition Examination Survey (NHANES): Vitamin B12 Status in Women of Reproductive Age. 2020. Https://www.cdc.gov/nchs/nhanes
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). Scientific Opinion on Dietary Reference Values for cobalamin (vitamin B12). EFSA Journal. 2015;13(4):4050.
- Ghosh, S. Et al. Vitamin B12 deficiency in pregnancy and offspring metabolic risk: a systematic review and meta-analysis. The Lancet Global Health. 2023;11(8):e1120-e1130. Doi:10.1016/S2214-109X(23)00256-7
- NHS. Vitamin B12 and folate deficiency anaemia. 2024. Https://www.nhs.uk/conditions/vitamin-b12-or-folate-deficiency-anaemia
